Ultra-long-acting removable drug delivery system for HIV treatment and prevention

被引:80
作者
Kovarova, Martina [1 ]
Benhabbour, S. Rahima [2 ]
Massud, Ivana [3 ]
Spagnuolo, Rae Ann [1 ]
Skinner, Brianna [4 ]
Baker, Caroline E. [1 ]
Sykes, Craig [5 ]
Mollan, Katie R. [6 ]
Kashuba, Angela D. M. [5 ]
Garcia-Lerma, J. Gerardo [3 ]
Mumper, Russell J. [2 ]
Garcia, J. Victor [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis,Ctr AIDS Res, 120 Mason Farm Rd CB 7042, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, UNC Eshelman Sch Pharm, Div Mol Pharmaceut, 125 Mason Farm Rd 4205, Chapel Hill, NC 27599 USA
[3] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Branch Lab, 1600 Clifton Rd,MS G45, Atlanta, GA 30329 USA
[4] Ctr Dis Control & Prevent, Comparat Med Branch, Div Sci Resources, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA
[5] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, UNC Eshelman Sch Pharm, 120 Mason Farm Rd CB 7361, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Ctr AIDS Res, 3126 McGavran Greenberg Hall, Chapel Hill, NC 27599 USA
关键词
HUMANIZED BLT MICE; FEMALE REPRODUCTIVE-TRACT; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL PROPHYLAXIS; AFRICAN WOMEN; INFECTION; DOLUTEGRAVIR; TENOFOVIR; TRANSMISSION; FORMULATION;
D O I
10.1038/s41467-018-06490-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Non-adherence to medication is an important health care problem, especially in the treatment of chronic conditions. Injectable long-acting (LA) formulations of antiretrovirals (ARVs) represent a viable alternative to improve adherence to HIV/AIDS treatment and prevention. However, the LA-ARV formulations currently in clinical trials cannot be removed after administration even if adverse events occur. Here we show an ultra-LA removable system that delivers drug for up to 9 months and can be safely removed to stop drug delivery. We use two pre-clinical models for HIV transmission and treatment, non-human primates (NHP) and humanized BLT (bone marrow/liver/thymus) mice and show a single dose of subcutaneously administered ultra-LA dolutegravir effectively delivers the drug in both models and show suppression of viremia and protection from multiple high-dose vaginal HIV challenges in BLT mice. This approach represents a potentially effective strategy for the ultra-LA drug delivery with multiple possible therapeutic applications.
引用
收藏
页数:11
相关论文
共 45 条
[1]   Single and multiple dose pharmacokinetics of dolutegravir in the genital tract of HIV-negative women [J].
Adams, Jessica L. ;
Patterson, Kristine B. ;
Prince, Heather M. A. ;
Sykes, Craig ;
Greener, Benjamin N. ;
Dumond, Julie B. ;
Kashuba, Angela D. M. .
ANTIVIRAL THERAPY, 2013, 18 (08) :1005-1013
[2]   Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity [J].
Anstett, Kaitlin ;
Cutillas, Vincent ;
Fusco, Robert ;
Mesplede, Thibault ;
Wainberg, Mark A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (08) :2083-2088
[3]   Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women [J].
Baeten, J. M. ;
Donnell, D. ;
Ndase, P. ;
Mugo, N. R. ;
Campbell, J. D. ;
Wangisi, J. ;
Tappero, J. W. ;
Bukusi, E. A. ;
Cohen, C. R. ;
Katabira, E. ;
Ronald, A. ;
Tumwesigye, E. ;
Were, E. ;
Fife, K. H. ;
Kiarie, J. ;
Farquhar, C. ;
John-Stewart, G. ;
Kakia, A. ;
Odoyo, J. ;
Mucunguzi, A. ;
Nakku-Joloba, E. ;
Twesigye, R. ;
Ngure, K. ;
Apaka, C. ;
Tamooh, H. ;
Gabona, F. ;
Mujugira, A. ;
Panteleeff, D. ;
Thomas, K. K. ;
Kidoguchi, L. ;
Krows, M. ;
Revall, J. ;
Morrison, S. ;
Haugen, H. ;
Emmanuel-Ogier, M. ;
Ondrejcek, L. ;
Coombs, R. W. ;
Frenkel, L. ;
Hendrix, C. ;
Bumpus, N. N. ;
Bangsberg, D. ;
Haberer, J. E. ;
Stevens, W. S. ;
Lingappa, J. R. ;
Celum, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) :399-410
[4]   Refilling drug delivery depots through the blood [J].
Brudno, Yevgeny ;
Silva, Eduardo A. ;
Kearney, Cathal J. ;
Lewin, Sarah A. ;
Miller, Alex ;
Martinick, Kathleen D. ;
Aizenberg, Michael ;
Mooney, David J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (35) :12722-12727
[5]   Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial [J].
Choopanya, Kachit ;
Martin, Michael ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Kitisin, Praphan ;
Natrujirote, Pitinan ;
Kittimunkong, Somyot ;
Chuachoowong, Rutt ;
Gvetadze, Roman J. ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Curlin, Marcel E. ;
Hendrix, Craig W. ;
Vanichseni, Suphak .
LANCET, 2013, 381 (9883) :2083-2090
[6]   Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir [J].
Cottrell, Mackenzie L. ;
Hadzic, Tanja ;
Kashuba, Angela D. M. .
CLINICAL PHARMACOKINETICS, 2013, 52 (11) :981-994
[7]   Role of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection [J].
Council, Olivia D. ;
Swanson, Michael D. ;
Spagnuolo, Rae Ann ;
Wahl, Angela ;
Garcia, J. Victor .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (12) :7847-7851
[8]   Generation of HIV Latency in Humanized BLT Mice [J].
Denton, Paul W. ;
Olesen, Rikke ;
Choudhary, Shailesh K. ;
Archin, Nancy M. ;
Wahl, Angela ;
Swanson, Michael D. ;
Chateau, Morgan ;
Nochi, Tomonori ;
Krisko, John F. ;
Spagnuolo, Rae Ann ;
Margolis, David M. ;
Garcia, J. Victor .
JOURNAL OF VIROLOGY, 2012, 86 (01) :630-634
[9]   One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates [J].
Denton, Paul W. ;
Othieno, Florence ;
Martinez-Torres, Francisco ;
Zou, Wei ;
Krisko, John F. ;
Fleming, Elisa ;
Zein, Sima ;
Powell, Daniel A. ;
Wahl, Angela ;
Kwak, Youn Tae ;
Welch, Brett D. ;
Kay, Michael S. ;
Payne, Deborah A. ;
Gallay, Philippe ;
Appella, Ettore ;
Estes, Jacob D. ;
Lu, Min ;
Garcia, J. Victor .
JOURNAL OF VIROLOGY, 2011, 85 (15) :7582-7593
[10]   Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice [J].
Denton, Paul W. ;
Estes, Jacob D. ;
Sun, Zhifeng ;
Othieno, Florence A. ;
Wei, Bangdong L. ;
Wege, Anja K. ;
Powell, Daniel A. ;
Payne, Deborah ;
Haase, Ashley T. ;
Garcia, J. Victor .
PLOS MEDICINE, 2008, 5 (01) :79-89